N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Supportive Care in Cancer

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00520-006-0018-9PMID 16450089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxaliplatin‐induced neurotoxicity and the development of neuropathy

  2005cited by this paper
• [Homocysteine in patients with diabetes mellitus].

  2004cited by this paper
• Homocisteína en el paciente con diabetes mellitus

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004influential reference
• Oxaliplatin‐induced neurotoxicity: Acute hyperexcitability and chronic neuropathy

  2004cited by this paper
• Homocysteine induces cell death of rat astrocytes in vitro.

  2003cited by this paper
• Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.

  2002influential reference
• Effects of Oral N-Acetylcysteine on Plasma Homocysteine and Whole Blood Glutathione Levels in Healthy, Non-pregnant Women

  2002cited by this paper
• Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.

  2001cited by this paper
• A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.

  2001cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Cisplatin‐Induced Apoptotic Cell Death in Mouse Hybrid Neurons Is Blocked by Antioxidants Through Suppression of Cisplatin‐Mediated Accumulation of p53 but Not of Fas/Fas Ligand

  2000cited by this paper
• Oxaliplatin: a review of preclinical and clinical studies.

  1998cited by this paper
• Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial.

  1995cited by this paper
• Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N‐acetylcysteine

  1995cited by this paper
• Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man.

  1990cited by this paper

• Efficacy of N-Acetyl Cysteine in the Treatment of Burning Mouth Syndrome—A Randomized Controlled Trial

  2025cites this paper
• Anti-oxidative stress therapies reduce chemotherapy-induced peripheral neuropathy in colorectal cancer patients treated with oxaliplatin: a systematic review and meta-analysis

  2025influential citation
• Anti-oxidative stress therapies prevent severe chemotherapy-induced peripheral neuropathy in colorectal cancer patients treated with oxaliplatin: a systematic review and meta-analysis

  2025cites this paper
• Evaluation of the Safety and Efficacy of N-acetylcysteine in the Prevention of Paclitaxel-induced Peripheral Neuropathy: A Randomized, Double-blind, and Placebo-controlled Trial

  2025cites this paper
• Application of the nanostructured R-AgLAFE electrode to study the electroreduction process of Bi(III) ions in the presence of N-acetylcysteine

  2023cites this paper
• The role of diet and non‐pharmacologic supplements in the treatment of chronic neuropathic pain: A systematic review

  2023cites this paper
• CISPLATIN - AN OVERVIEW OF ITS EFFICIENCY AND TOXICITY

  2023cites this paper
• The Therapeutic Potential of Antioxidants in Chemotherapy-Induced Peripheral Neuropathy: Evidence from Preclinical and Clinical Studies

  2023cites this paper
• Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis

  2022cites this paper
• Nutraceuticals for Prevention of Chemotherapy-Induced Peripheral Neuropathy

  2022cites this paper
• Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs

  2022cites this paper
• Antioxidant and Neuroprotective Effect of a Grape Pomace Extract on Oxaliplatin-Induced Peripheral Neuropathy in Rats: Biochemical, Behavioral and Histopathological Evaluation

  2022cites this paper
• Ocoxin as a complement to first line treatments in cancer

  2021cites this paper
• Antioxidants improve oxaliplatin-induced peripheral neuropathy in tumor-bearing mice model: role of spinal cord oxidative stress and inflammation.

  2021cites this paper
• The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics.

  2020cites this paper
• Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial

  2020influential citation
• Chemotherapy-Induced Peripheral Neuropathy

  2020cites this paper
• Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial

  2020cites this paper
• Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study

  2020cites this paper
• Ameliorative Effects Of N-Acetylcysteine As Adjunct Therapy On Symptoms Of Painful Diabetic Neuropathy

  2019cites this paper
• First report on BaltCRP, a cysteine-rich secretory protein (CRISP) from Bothrops alternatus venom: Effects on potassium channels and inflammatory processes.

  2019cites this paper
• Integrative Treatment for Colorectal Cancer: A Comprehensive Approach

  2018cites this paper
• Natural products - alpha-lipoic acid and acetyl-L-carnitine - in the treatment of chemotherapy-induced peripheral neuropathy.

  2018cites this paper
• The Clinical Use of N-Acetylcysteine in Other Medical Disorders

  2018cites this paper
• Unraveling the in vitro antitumor activity of Vismia baccifera against HepG2: role of hydrogen peroxide

  2018cites this paper
• EXPLORATION OF METFORMIN EFFECT OVER OXALIPLATIN ANTINEOPLASIC PROPERTIES IN MKN45, KATOIII AND HS746T GASTRIC CANCER CELL LINES IN VITRO AND OVER OXALIPLATIN INDUCED RAT PAINFUL SENSORY NEUROPATHY IN VIVO.

  2018cites this paper
• Application of N-Acetylcysteine in Neurological Disorders

  2018cites this paper
• Stratégie thérapeutique des neuropathies périphériques chimio-induites

  2018cites this paper
• In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials

  2018cites this paper
• Anemia, Depression, and Suicidal Attempts in Women: Is There a Relationship?

  2018cites this paper
• Pharmacological Approaches and Natural Products for Prevention of Chemotherapy-Induced Peripheral Neuropathy - A Review

  2017cites this paper
• Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy.

  2017cites this paper
• Lifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review

  2017cites this paper
• Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy

  2017cites this paper
• Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy

  2017influential citation
• Chemotherapy-induced peripheral neuropathy: limitations in current prophylactic strategies and directions for future research

  2017cites this paper
• Cisplatin‐induced mitochondrial dysfunction is associated with impaired cognitive function in rats

  2017cites this paper
• Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity†

  2017cites this paper
• Investigating chemotherapy induced peripheral neuropathy (CIPN) and its treatment, using functional Magnetic Resonance Imaging (fMRI)

  2017cites this paper
• A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy

  2016cites this paper
• Gingko Biloba versus Neuropeptide Derivative FPF 1070 (Cerebrolysin) Effect against Cisplatin-Induced Sciatic Neuropathy

  2016cites this paper
• New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy

  2016cites this paper
• Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.

  2016cites this paper
• Chemotherapy-induced peripheral neuropathic pain

  2016cites this paper
• The Role of N-acetyl-L-Cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients with Inadequately Controlled Chronic Neuropathic Pain

  2016cites this paper
• A Novel Approach to Peritoneal Dissemination of Mucin-Expressing Malignancies of Gastrointestinal Origin

  2016cites this paper
• Cigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMT.

  2016cites this paper
• Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies

  2016cites this paper
• Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment

  2016cites this paper
• Pain Syndromes Associated with Cancer Therapy

  2016cites this paper
• Incidence, Prevalence and Predictors of Chemotherapy Induced Peripheral Neuropathy

  2016cites this paper
• Oral administration of the amino acids cystine and theanine attenuates the adverse events of S-1 adjuvant chemotherapy in gastrointestinal cancer patients

  2016cites this paper
• National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons

  2016cites this paper
• Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities

  2016cites this paper
• Chemotherapy-induced peripheral neuropathy.

  2015cites this paper
• Antioxidant supplementation on cancer risk and during cancer therapy: an update.

  2015cites this paper
• linical trials of N-acetylcysteine in psychiatry and neurology : systematic

  2015cites this paper
• Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

  2015cites this paper
• [Properties of the Measures to Assess Oxaliplatin-induced Peripheral Neuropathy: A Literature Review].

  2015cites this paper
• Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine

  2015cites this paper
• Incidence, prevalence, and predictors of chemotherapy‐induced peripheral neuropathy: A systematic review and meta‐analysis

  2014cites this paper
• A Mouse Model of Peripheral Postischemic Dysesthesia: Involvement of Reperfusion-Induced Oxidative Stress and TRPA1 Channel

  2014cites this paper
• Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice

  2014cites this paper
• Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy

  2014cites this paper
• Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy

  2014cites this paper
• Mitotoxicity in distal symmetrical sensory peripheral neuropathies

  2014cites this paper
• Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.

  2014cites this paper
• North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study

  2014cites this paper
• Occupational exposure to municipal solid wastes and development of toxic neuropathies: Possible role of nutrient supplementation, complementary and alternative medicines in chemoprevention

  2014cites this paper
• Interventions for preventing neuropathy caused by cisplatin and related compounds.

  2014cites this paper
• Dorsal root ganglion disorders

  2014cites this paper
• Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

  2014cites this paper
• Efficacité d’un tableau d’ajustement de l’oxaliplatine selon le grade de neuropathie à l’Hôtel-Dieu de Québec

  2014cites this paper
• Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)

  2013cites this paper
• Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors

  2013cites this paper
• Neuropathy in the Cancer Patient : Causes and Cures

  2013cites this paper
• Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.

  2013cites this paper
• Chemotherapy‐induced peripheral neurotoxicity: A critical analysis

  2013cites this paper
• Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin‐induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization

  2012cites this paper
• Chemotherapy-induced peripheral neuropathy. Part II. Prevention

  2012cites this paper
• N-acetylcysteine as an anti-oxidant and anti-inflammatory drug and its some clinical applications

  2012cites this paper
• Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.

  2012cites this paper
• The role of the organic cation/carnitine transporters in the uptake and neurotoxicity of oxaliplatin

  2012cites this paper
• Obwodowa neuropatia wywołana chemioterapią. Część II. Zapobieganie

  2012cites this paper
• Neurological complications of chemotherapy to the peripheral nervous system.

  2012cites this paper
• Chemotherapy‐Induced Peripheral Neuropathy: Prevention and Treatment

  2011cites this paper
• Acute neurotoxicity induced by common chemotherapies

  2011cites this paper
• Systematic Review: Generating Evidence-Based Guidelines on the Concurrent Use of Dietary Antioxidants and Chemotherapy or Radiotherapy

  2011cites this paper
• The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen

  2011cites this paper
• The pivotal role of intracellular calcium in oxaliplatin-induced inhibition of neurite outgrowth but not cell death in differentiated PC12 cells.

  2011cites this paper
• Interventions for preventing neuropathy caused by cisplatin and related compounds.

  2011cites this paper
• Oxaliplatin-Induced Neuropathy in Colorectal Cancer

  2011cites this paper
• Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.

  2010cites this paper
• Neuromuscular Disease and Spinal Cord Compression

  2010cites this paper
• Vincristine-induced Peripheral Neuropathy in a Neonate With Congenital Acute Lymphoblastic Leukemia

  2010cites this paper
• The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.

  2010cites this paper
• [Chemotherapy-induced peripheral neuropathy: an unresolved issue].

  2010cites this paper
• Neuropatía inducida por el tratamiento médico del cáncer

  2010cites this paper
• The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.

  2010cites this paper
• Micronutrients in Improvement of the Standard Therapy in Cancer

  2010cites this paper